What prognostic factors are important in duodenal adenocarcinoma?

PubWeight™: 2.03‹?› | Rank: Top 2%

🔗 View Article (PMID 10843358)

Published in Arch Surg on June 01, 2000

Authors

F G Bakaeen1, M M Murr, M G Sarr, G B Thompson, M B Farnell, D M Nagorney, D R Farley, J A van Heerden, L M Wiersema, C D Schleck, J H Donohue

Author Affiliations

1: Department of Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minn. 55905, USA.

Articles citing this

Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment. Ann Surg Oncol (2011) 1.24

Recent advances in the management of adenocarcinoma of the small intestine. Gastrointest Cancer Res (2009) 1.14

Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis. World J Surg (2006) 1.03

Treatment for superficial non-ampullary duodenal epithelial tumors. World J Gastroenterol (2014) 1.02

Small bowel adenocarcinomas--existing evidence and evolving paradigms. Nat Rev Clin Oncol (2013) 0.99

Prognostic factors in primary adenocarcinoma of the small intestine: 13-year single institution experience. World J Surg Oncol (2008) 0.96

Surgically treated primary malignant tumor of small bowel: a clinical analysis. World J Gastroenterol (2010) 0.95

Longterm survival after pancreaticoduodenectomy for periampullary adenocarcinomas. HPB (Oxford) (2013) 0.94

Prognostic factors for primary duodenal adenocarcinoma. World J Surg (2008) 0.91

Adenocarcinoma of the third duodenal portion: Case report and review of literature. World J Gastrointest Surg (2012) 0.89

Prognostic factors associated with survival in patients with primary duodenal adenocarcinoma. Korean J Intern Med (2011) 0.89

Pancreas-sparing total duodenectomy for ampullary duodenal neoplasms. World J Surg (2012) 0.87

Clinicopathological characteristics and survival analysis of primary duodenal cancers: a 14-year experience in a tertiary centre in South China. Int J Colorectal Dis (2010) 0.86

Impact of reconstruction methods on outcome of pancreatoduodenectomy in pancreatic cancer patients. World J Surg (2005) 0.85

Annular pancreas associated with duodenal carcinoma. World J Gastroenterol (2010) 0.84

Malignant Tumor at D-4 Mimicking Wilkie's Syndrome. Indian J Surg (2011) 0.82

Duodenal adenocarcinoma: Advances in diagnosis and surgical management. World J Gastrointest Surg (2016) 0.82

Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma. Langenbecks Arch Surg (2012) 0.79

KRAS G>A mutation favors poor tumor differentiation but may not be associated with prognosis in patients with curatively resected duodenal adenocarcinoma. Int J Cancer (2013) 0.79

Clinical analysis of primary anaplastic carcinoma of the small intestine. World J Gastroenterol (2009) 0.78

Adenocarcinoma of the third portion of the duodenum in a man with CREST syndrome. World J Surg Oncol (2008) 0.78

Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma. Hum Pathol (2013) 0.78

Pancreas-sparing duodenectomy for an obstructive adenocarcinoma of the duodenum. J Surg Case Rep (2012) 0.77

Small bowel adenocarcinoma - terra incognita: A demand for cross-national pooling of data. Oncol Lett (2014) 0.77

[Primary malignant tumors of the small intestine: clinical and therapeutic aspects of 27 patients]. Pan Afr Med J (2011) 0.75

Primary Duodenal Adenocarcinoma without Stenosis: A Case Report with a Brief Literature Review. Case Rep Oncol (2014) 0.75

Duodenal adenocarcinoma masked by acute cholecystitis and peptic ulcer disease. BMJ Case Rep (2013) 0.75

Malignant tumor at the fourth part of duodenum mimicking wilkie syndrome. Indian J Surg (2011) 0.75

Preclinical trial on the use of doxycycline for the treatment of adenocarcinoma of the duodenum. Mol Clin Oncol (2016) 0.75

Adenocarcinoma of the duodenojejunal flexure presenting as a stricturous lesion. BMJ Case Rep (2014) 0.75

Prognostic Factors and Clinical Characteristics of Patients with Primary Duodenal Adenocarcinoma: A Single-Center Experience from China. Biomed Res Int (2016) 0.75

Adenocarcinoma of the third and fourth portions of the duodenum: The capsule endoscopy value. World J Gastroenterol (2015) 0.75

Radical resection of a primary unresectable duodenal cancer after chemotherapy using S-1 and cisplatin: report of a case. Surg Case Rep (2017) 0.75

Double primary tumors-renal cell carcinoma and duodenal mucinous adenocarcinoma. Balkan Med J (2012) 0.75

Early duodenal adenocarcinoma resembling a submucosal tumor cured with endoscopic resection: a case report. J Med Case Rep (2012) 0.75

A novel "salvage" indication to intestinal derotation procedure: reconstruction after duodenopancreatectomy. Am J Case Rep (2014) 0.75

Primary undifferentiated carcinoma of the small intestine: an immunohistochemical study and review of the literature. Med Mol Morphol (2010) 0.75

An early superficial non-ampullary duodenal tumor cured with endoscopic submucosal dissection: A case report. Oncol Lett (2017) 0.75

Articles by these authors

Biliary tract cancers. N Engl J Med (1999) 6.36

Mesenteric venous thrombosis. N Engl J Med (2001) 5.87

Surgical management of intussusception in the adult. Ann Surg (1981) 5.42

Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84

Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg (1995) 4.17

Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology (1997) 4.10

Metastasis to the thyroid gland. A report of 43 cases. Cancer (1997) 4.08

Resection of hepatic metastases from colorectal cancer. Arch Surg (1984) 4.06

Complications following pancreaticoduodenectomy. Current management. Arch Surg (1992) 3.94

Adenocarcinoma of the stomach: are we making progress? Lancet (1993) 3.68

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst (2001) 3.37

The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med (1997) 3.31

Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab (2001) 3.19

Optimal testing parameters for blood cultures. Clin Infect Dis (2004) 3.17

Primary venous leiomyosarcoma: a rare but lethal disease. J Vasc Surg (1992) 3.05

Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg (1992) 2.97

Laparoscopically assisted panenteroscopy: a feasibility study in pigs. Gastrointest Endosc (1995) 2.84

Pancreatic anastomotic leak after pancreaticoduodenectomy: incidence, significance, and management. Am J Surg (1994) 2.69

Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int (2007) 2.69

Prevention of infection in critically ill patients by selective decontamination of the digestive tract. Ann Intern Med (1992) 2.60

The natural history of surgically treated primary adenocarcinoma of the appendix. Ann Surg (1994) 2.59

Comparison of LightCycler PCR, rapid antigen immunoassay, and culture for detection of group A streptococci from throat swabs. J Clin Microbiol (2003) 2.57

A prospective randomized comparison of laparoscopic appendectomy with open appendectomy: Clinical and economic analyses. Surgery (2001) 2.57

Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol (1998) 2.51

Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery (2001) 2.50

Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg (1994) 2.50

Primary hepatic malignancy: surgical management and determinants of survival. Surgery (1989) 2.35

Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Members of the Pancreas Clinic, and Pancreatic Surgeons of Mayo Clinic. Gastroenterology (1996) 2.33

Surgical management of unresectable carcinoma of the pancreas. Surgery (1982) 2.30

Outcomes after curative resections of cholangiocarcinoma. Arch Surg (1993) 2.26

Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg (1997) 2.13

The fate of interleukin-2 after in vivo administration. J Immunol (1983) 2.13

Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes. J Clin Endocrinol Metab (1999) 2.06

Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery (1992) 2.06

Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann Surg (2000) 2.05

Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut (2001) 2.05

Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc (1991) 2.04

Preoperative recognition of intestinal strangulation obstruction. Prospective evaluation of diagnostic capability. Am J Surg (1983) 1.99

Carcinoid tumor of the appendix: treatment and prognosis. N Engl J Med (1987) 1.99

Long-term outcomes (>5-year follow-up) with porcine acellular dermal matrix (Permacol) in incisional hernias at risk for infection. Hernia (2013) 1.97

"Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc (1995) 1.97

The spectrum of serous cystadenoma of the pancreas. Clinical, pathologic, and surgical aspects. Ann Surg (1992) 1.96

Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg (1999) 1.94

Nonmeckelian jejunal or ileal diverticulosis: an analysis of 112 cases. Surgery (1994) 1.92

Total pancreatectomy for ductal adenocarcinoma of the pancreas. Mayo Clinic experience. Am J Surg (1981) 1.90

Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J Surg (1996) 1.88

Mesenteric venous thrombosis: still a lethal disease in the 1990s. J Vasc Surg (1994) 1.86

Nonpancreatic primary tumors with metastasis to the pancreas. Surg Gynecol Obstet (1989) 1.85

Obstructive sleep apnoea and perioperative complications in bariatric patients. Br J Anaesth (2010) 1.85

Hyperparathyroidism and pancreatitis. Chance or a causal association? JAMA (1980) 1.85

Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc (1986) 1.84

Acute cholecystitis as a complication in surgical patients. Arch Surg (1984) 1.83

Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg (1995) 1.82

Solitary pulmonary nodules: clinical prediction model versus physicians. Mayo Clin Proc (1999) 1.81

Endosonography-guided celiac plexus neurolysis. Gastrointest Endosc (1996) 1.81

Recent developments in the diagnosis and treatment of pheochromocytoma. Mayo Clin Proc (1990) 1.80

Spontaneous rupture of the spleen due to infectious mononucleosis. Mayo Clin Proc (1992) 1.80

Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg (1991) 1.78

Pancreatic lymphoma: is it a surgical disease? Pancreas (1994) 1.77

Characteristics of biliary tract complications during laparoscopic cholecystectomy: a multi-institutional study. Am J Surg (1994) 1.76

Ruptured abdominal aortic aneurysms: repair should not be denied. J Vasc Surg (1992) 1.75

Prospective evaluation of Roux-en-Y gastric bypass as primary operation for medically complicated obesity. Mayo Clin Proc (2000) 1.74

Selected management of pancreatic pseudocysts: operative versus expectant management. Surgery (1992) 1.72

Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res (1990) 1.72

Neuroendocrine ampullary tumors: spectrum of disease including the first report of a neuroendocrine carcinoma of non-small cell type. Surgery (1994) 1.72

Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil. Int J Radiat Oncol Biol Phys (1993) 1.71

Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol (1999) 1.69

Culture with BACTEC Peds Plus/F bottle compared with conventional methods for detection of bacteria in synovial fluid. J Clin Microbiol (2001) 1.68

Long-term consequences of intraoperative spillage of bile and gallstones during laparoscopic cholecystectomy. J Gastrointest Surg (2006) 1.68

The significance of sinistral portal hypertension complicating chronic pancreatitis. Am J Surg (2000) 1.67

Replacement of the inferior vena cava for malignancy: an update. J Vasc Surg (2000) 1.66

Reexploration for symptomatic hematomas after cervical exploration. Surgery (2001) 1.66

Survival after surgical treatment for primary hyperparathyroidism. Surgery (1997) 1.66

Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. World J Surg (2001) 1.64